Higher Pentraxin-3 Level in Patients with Metabolic Syndrome Reply

dc.contributor.authorKarakas, Mehmet Fatih
dc.contributor.authorBuyukkaya, Eyup
dc.contributor.authorKurt, Mustafa
dc.contributor.authorKarakas, Esra
dc.contributor.authorBuyukkaya, Sule
dc.date.accessioned2024-09-18T21:07:49Z
dc.date.available2024-09-18T21:07:49Z
dc.date.issued2013
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpage514en_US
dc.identifier.issn1011-7571
dc.identifier.issue5en_US
dc.identifier.startpage513en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/13973
dc.identifier.volume22en_US
dc.identifier.wosWOS:000324588400021en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofMedical Principles and Practiceen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleHigher Pentraxin-3 Level in Patients with Metabolic Syndrome Replyen_US
dc.typeLetteren_US

Dosyalar